Lorazepam for Status Epilepticus - Patient Care - @ JEMS.com

Lorazepam for Status Epilepticus


Keith Wesley, MD, FACEP | | Tuesday, June 26, 2007

Review of: Lang ES, Andruchow JE: What is the preferred first-line therapy for status epilepticus? Annals of Emergency Medicine. 2006. 48:98–100.

The Science

This abstract, which appeared in Annals of Emergency Medicine, strives to provide support for Evidence-Based Emergency Medicine (EBEM). The abstract is based on a systematic review from the Cochrane Database of Systematic Reviews titled "Anticonvulsant therapy for status epilepticus" 2006, Issue 1, article number CD003723. The Cochrane Database is one of the most respected databases of scientific literature and allows researchers the ability to perform quality comparisons of studies (aka, a meta-analysis) to determine the trend for or against a particular intervention.

This abstract supports the routine use of lorazepam intravenously as the first-line drug of choice to stop status epilepticus, which the authors define as seizure activity lasting more than 30 minutes or two or more consecutive seizures without a return to full consciousness. Lorazepam was clinically significant to both diazepam and midazolam at stopping seizure activity. However, there was no difference between the agents in regard for the need to provide ventilatory support or other complications.

The Street

It's important that our practice of both in- and out-of-hospital medicine be based on evidence. Sometimes, the only way to make a decision regarding best practice is to examine the results of many studies that include all possible patient populations. The Cochrane Database provides this type of resource.

In this case, the questions is whether to use lorazepam or diazepam for status epilepticus. However, the definition of status as used by the authors isn't consistent with that used by EMS, which usually defines it as seizure activity lasting no more than 10 minutes. We generally don't like to transport patients actively seizing and will give them a minute or two (however long it takes to get the IV started) and then treat them.

Whether the same findings regarding lorazepam woul hold true for prehospital seizure control isn't clear, and no randomized controlled studies exist. Therefore, we're left to extrapolate this study into our practice.

The take home message is that at least there is no disadvantage to using lorazepam over diazepam. Although it has been the opinion of many, including myself, that lorazepam results in less respiratory suppression, this study indicates there is no difference. But that may be true only with regard to status epilepticus where the patient is more profoundly acidotic. Further studies are needed to determine what amount of each of these medications is needed to stop the types of seizure activity frequently seen in EMS before we can make an evidence-based decision.

Connect: Have a thought or feedback about this? Add your comment now
Related Topics: Patient Care, Medical Emergencies, Research

Author Thumb

Keith Wesley, MD, FACEP

Keith Wesley, MD, FACEP, is the Minnesota State EMS medical director and the EMS medical director for HealthEast Ambulance in St. Paul, Minn. and and can be reached at drwesley@emsconsulting.net.


What's Your Take? Comment Now ...

Buyer's Guide Featured Companies

Featured Careers & Jobs in EMS

Get JEMS in Your Inbox


Fire EMS Blogs

Blogger Browser

Today's Featured Posts


EMS Airway Clinic

Improving Survival from Cardiac Arrest Using ACD-CPR + ITD

Using active compression-decompression CPR with an ITD has been shown to improve 1-year survival from cardiac arrest by 33%.
More >

Multimedia Thumb

Three Injured in Philadelphia Collapse

Parapet wall falls through roof of store.
Watch It >

Multimedia Thumb

California Firefighters save Man on Flight

Patient was conscious and talking when United flight landed.
Watch It >

Multimedia Thumb

Over Half of Seattle Fire Stations Test Positive for MRSA

Surprisingly high results come from test kits based on earlier study.
Watch It >

Multimedia Thumb

Hands On February 2015

Here’s a look at this month’s product hands on.
More >

Multimedia Thumb

Nightwatch Series Premiere Party

JEMS Editor-in-Chief A.J. Heightman attends the series premiere of A&E's new reality show, "Nightwatch."
More >

Multimedia Thumb

Ottawa Chemical Investigation

Chemicals and suspicious package are probed at two locations
More >

Multimedia Thumb

LMA MAD Nasal™

Needle-free intranasal drug delivery.
Watch It >

Multimedia Thumb

The AmbuBus®, Bus Stretcher Conversion Kit - EMS Today 2013

AmbuBus®, Bus Stretcher all-hazards preparedness & response tool
Watch It >

Multimedia Thumb

VividTrac offered by Vivid Medical - EMS Today 2013

VividTrac, affordable high performance video intubation device.
Watch It >

More Product Videos >